Citigroup’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-348
Closed -$2.04K 5959
2023
Q4
$2.04K Buy
348
+337
+3,064% +$3.99K ﹤0.01% 5415
2023
Q3
$285 Sell
11
-763
-99% -$62.7K ﹤0.01% 5282
2023
Q2
$108K Buy
774
+726
+1,513% +$93.2K ﹤0.01% 4215
2023
Q1
$4.37K Sell
48
-20
-29% -$2.71K ﹤0.01% 4975
2022
Q4
$9.3K Sell
68
-4,595
-99% -$1.56M ﹤0.01% 4862
2022
Q3
$4.04M Buy
4,663
+3,542
+316% +$2.22M ﹤0.01% 1664
2022
Q2
$491K Sell
1,121
-370
-25% -$193K ﹤0.01% 3241
2022
Q1
$947K Sell
1,491
-13,268
-90% -$8.36M ﹤0.01% 3022
2021
Q4
$13.2M Buy
14,759
+998
+7% +$1.05M 0.01% 1231
2021
Q3
$17.4M Buy
13,761
+11,243
+447% +$13.6M 0.01% 1082
2021
Q2
$3.05M Buy
+2,518
New +$3.4M ﹤0.01% 2325
2021
Q1
Sell
-50
Closed -$66K 7661
2020
Q4
$66K Buy
+50
New +$57.2K ﹤0.01% 5849

Other funds holding CANO

Citigroup's CANO Position: Q1 2024 in Review

Citigroup sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 348 shares — an estimated $2.04K sold.

Citigroup first reported a position in CANO in Q4 2020 and held it in 12 quarters. The position peaked at $17.4M in Q3 2021. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Citigroup reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Citigroup sold 348 Cano Health, Inc. shares in Q1 2024, an estimated $2.04K.
  • Citigroup first reported a position in Cano Health, Inc. in Q4 2020 and held it in 12 quarters.
  • Citigroup's Cano Health, Inc. position peaked at $17.4M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.